Acute stent thrombosis after percutaneous coronary intervention (PCI) is still problematic because of the subsequent development of myocardial infarction and poor prognosis. The incidence of acute stent thrombosis, occurring within 0-24hours after PCI, is relatively low, but underlying causes and treatment strategy are not well defined. Multi-vessel disease, ST-elevated myocardial infarction (STEMI), and large thrombotic burden are known risk factors of acute stent thrombosis. Thrombus aspiration, balloon angioplasty and glycoprotein IIb/IIIa receptor blocker could be therapeutic options.
INTRODUCTION
After the advent of percutaneous coronary intervention (PCI), mortality of acute coronary syndrome continues to decline, but stent thrombosis (ST) after PCI remains a residual problem of the procedure. ST occurs about 1-2% of total PCI cases [1] [2] [3] [4] [5] [6] [7] and acute stent thrombosis, occurring within 0-24hours after PCI, accounts for 6-25% of all ST cases. 1, 8 Although the incidence of ST is relatively low, prognosis of ST is dismal; with a case-fatality rate of 15-45%. 5, 7 Nonetheless underlying causes and treatment strategy of ST are not-well defined.
Physician's concept or suspicion of acute stent thrombosis can be enough for the diagnosis and improve the prognosis of those patients. Here we report two cases of acute stent thrombosis during PCI for one patient with ST-elevated myocardial infarction (STEMI) and the other with acute coronary syndrome, which were successfully 
CASE 2
A 83 year-old woman was referred to our hospital with mm Xience V stent, Abbott) were inserted in the proximal and middle LAD at first ( Fig. 4-B) , followed by two more Everolimus eluting stents insertion in the proximal LCX.
After successful treatment with LCX artery, she complained of chest discomfort. CAG and intravenous ultrasonography (IVUS) revealed acute stent thrombosis in the mid-portion of LAD artery ( Fig. 4-C) . Thrombus aspiration and infusion of glycoprotein IIb/IIIa receptor blocker were done, and post-treatment CAG showed patent coronary flow ( Fig. 4-D) . After PCI, pulmonary edema disappeared and she showed the improvement of functional status. There were no predisposing factors including abnormal findings of coagulation system such as protein C or S, anti-phospholipid antibody and no evidence of malignancy. She was discharged with triple anti-platelet therapy using aspirin 100 mg, clopidogrel 75 mg, and cilostazol 200 mg daily. The patient was followed up via outpatient clinic without symptoms, repeat CAG after 9 months showed patent coronary flow. 
DISCUSSION

CONCLUSION
Acute ST during PCI was associated with multi-vessel disease, STEMI, and large thrombotic burden. Therefore, acute stent thrombosis can be successfully treated with thrombus aspiration, potent platelet aggregation inhibitor and balloon angioplasty.
